University of Groningen Insight in psychosis de Vos, Annerieke · Publisher's PDF, also known as...
Transcript of University of Groningen Insight in psychosis de Vos, Annerieke · Publisher's PDF, also known as...
University of Groningen
Insight in psychosisde Vos, Annerieke
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite fromit. Please check the document version below.
Document VersionPublisher's PDF, also known as Version of record
Publication date:2016
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):de Vos, A. (2016). Insight in psychosis: Metacognitive processes and treatment. [Groningen]:Rijksuniversiteit Groningen.
CopyrightOther than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of theauthor(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policyIf you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediatelyand investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons thenumber of authors shown on this cover page is limited to 10 maximum.
Download date: 11-08-2020
72
Annerieke E. de VosLisette van der MeerJan-Bernard C. MarsmanJohan A. ArendsAndré AlemanGerdina H. M. Pijnenborg
Submitted
73
74
75
Table 1. Demographic and clinical characteristics at baseline (T1) for the clinical and cognitive insight change groups. Increased clinical
insight group N Decreased clinical
insight group N P
Variable Mean (SD) Mean (SD) Age (years) 30.71 (7.92) 17 40.83 (11.29) 12 T=2.86; P=0.008 Level of educationᵃ 5.29 (0.84) 17 5.08 (1.16) 12 n.s Gender (percentage male) 88% 17 50% 12 X²= 2.42; P=0.038 PANSS (score) 431.18 (321.63) 367.92 (186.65) n.s. Total 57.29 (14.54) 17 56.58 (7.50) 12 n.s. Positive 15.57 (5.01) 17 12.58 (3.26) 12 n.s. Negative 12.88 (4.72) 17 14.42 (4.75) 12 n.s General psychopathology 28.94 (6.72) 17 29.58 (4.18) 12 n.s SAI-E subtotal 10.98 (3.85) 17 15.39 (4.77) 12 T=-2.75; P=0.01 Antipsychotic medicationᵇ 431.17 (321.63) 12 367.92 (186.65) 12 n.s. Number of psychotic episodes 3.88 (3.44) 12 2.50 (2.10) 12 n.s. Duration of illness 7.89 (6.19) 12 12.17 (9.93) 12 n.s. Increased
cognitive insight group
N Decreased cognitive insight
group
N
Variable Mean (SD) Mean (SD) Age (years) 33.50 (10.56) 12 33.23 (10.20) 13 n.s. Level of educationᵃ 5.08 (1.16) 12 5.15 (0.80) 13 n.s. Gender (percentage male) 75% 12 62% 13 n.s. PANSS (score) Total 57.83 (7.43) 12 56.08 (16.63) 13 n.s. Positive 12.92 (3.57) 12 15.00 (5.68) 13 n.s. Negative 14.17 (4.06) 12 13.46 (5.75) 13 n.s. General psychopathology 30.75 (3.77) 12 27.62 (7.26) 13 n.s. BCIS composite score 4.17 (4.44) 12 10.54 (3.38) 13 T= 0.70; P =0.001 Antipsychotic medicationᵇ 385.84 (217.79) 12 416.54 (276.05) 13 n.s. Number of psychotic episodes 3.42 (2.87) 12 2.85 (2.64) 13 n.s. Duration of illness 10.92 (9.38) 12 7.93 (7.67) 13 n.s. ᵃEducation level according to Verhage (1964). ᵇStandardized anti-psychotic dose based on chlorpromazine equivalents (Gardner et al., 2010).
76
77
78
79
80
81